SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tonyt who wrote (1021)1/8/1998 7:26:00 PM
From: D.Right  Read Replies (1) of 2173
 
Dear Tony: Haven't seen your post here for quite a while. Believe it or not, AMLN made the number 46 of Deloitte & Touche Fast 500 Growing Technology Companies. It is based on the revenues growth over the 92-96 period. AMLN's revenue shows around 2000% increase over that period of time mainly because of the 50% development cost paid by JNJ for pramlintide. Here is the link:
biz.yahoo.com
biz.yahoo.com

D.Right
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext